Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02246226PMID 1546132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.

  1990cited by this paper
• Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

  1989cited by this paper
• Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

  1989cited by this paper
• [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B.

  1989cited by this paper
• Enzyme-activated/mechanism-based inhibitors.

  1987cited by this paper
• Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

  1985cited by this paper
• The kinetics of reversible tight-binding inhibition.

  1979cited by this paper
• [17] The kinetics of reversible tight-binding inhibition

  1979cited by this paper

• Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.

  2016cites this paper
• Antidepressant effect and categorization of inhibitory activity of monoamine oxidase type A and B of ethanolic extract of seeds of Trigonella foenum graecum Linn.

  2014cites this paper
• Inhibitor design for monoamine oxidases.

  2013cites this paper
• CHARLES UNIVERSITY IN PRAGUE

  2012cites this paper
• Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.

  2010cites this paper
• Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypes.

  2007cites this paper
• Biochemistry and pharmacology of moclobemide, a prototype RIMA

  2005cites this paper
• Mechanistic Pharmacokinetic and Pharmacodynamic Modeling of CHF3381 (2-[(2,3-Dihydro-1H-inden-2-yl)amino]acetamide Monohydrochloride), a Novel N-Methyl-d-aspartate Antagonist and Monoamine Oxidase-A Inhibitor in Healthy Subjects

  2005cites this paper
• Effect of oral linezolid on the pressor response to intravenous tyramine.

  2004cites this paper
• Monoamine oxidase inhibition by N-alkyloxycarbonyl derivatives of ethylene diamine.

  2000cites this paper
• Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices-implication for its neuroprotective properties.

  2000cites this paper
• N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.

  1998cites this paper
• Regional action of brofaromine on rat brain MAO-A and MAO-B.

  1998cites this paper
• [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].

  1997cites this paper
• A Risk-Benefit Assessment of Moclobemide in the Treatment of Depressive Disorders

  1995cites this paper
• Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.

  1994cites this paper
• Can our knowledge of monoamine oxidase (MAO) help in the design of better MAO inhibitors?

  1994cites this paper
• Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases.

  1994cites this paper
• Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.

  1993cites this paper
• The new generation of monoamine oxidase inhibitors.

  1992cites this paper